Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 07/31/12
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 10/31/11
Due: 10/31/12
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views | NCT01708746 | Verinata Health, Inc. | user2@example.com | None | 2012-11-30 | 2013-10-31 | 2014-10-31 | - | - | 2025-07-14 |
| Comparison of Aneuploidy Risk Evaluations | NCT01663350 | Verinata Health, Inc. | user2@example.com | None | 2012-07-31 | - | - | - | - | 2025-07-14 |
| MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy | NCT01122524 | Verinata Health, Inc. | user2@example.com | None | 2010-06-30 | 2011-10-31 | 2012-10-31 | - | - | 2025-07-14 |